40 reports

  • Mexico Acne Treatment Market
  • EUROPE ACNE TREATMENT MARKET,

BARRIERS TO ENTRY - HIGH Porter Five Force Model: Acne Treatment Market BUYER' S POWER - MODERATE ##.

  • Acne Treatment
  • North America
  • World
  • Market Size
  • Allergan plc
  • Other acne treatment
  • Products & Markets

Clearasil is one of the oldest names in OTC acne treatment, debuting in 1950.

  • Acne Treatment
  • OTC
  • United States
  • Demand
  • 2.3 Acne Treatment
  • 2.3.2 Acne Treatment Continuum

First Choice (First Line Treatment) Alternative Treatment Maintenance Therapy Mild Moderate Severe ##) SYSTEMATIC THERAPY ##. ## Acne Treatment Systematic therapy refers to Acne medication that is taken by mouth.

  • Acne Treatment
  • World
  • Market Size
  • Actavis plc
  • Allergan plc
  • Sep 04, 2018: Sol-Gel Technologies provides program update for TWIN for the treatment of acne vulgaris
  • Dec 17, 2018: Sol-Gel Technologies initiates pivotal phase III clinical program of TWIN for the treatment of acne vulgaris

Its twin drug candidate is a non-antibiotic topical cream developed for the treatment of acne vulgaris or acne.

  • Acne Treatment
  • Therapy
  • United States
  • Product Initiative
  • Syros Pharmaceuticals, Inc.

Global Market Study on Acne Treatment: Inflammatory Acne Segment Anticipated to Account for ## BPS Gain in Market Revenue Share During 2017 – 2025 ##.

  • Acne Treatment
  • OTC
  • Pharmaceutical
  • World
  • Market Size
  • COMPANY S LEAD ACNE TREATMENT, BTX-1503. THE NEW PATENT APPLICATIONS WERE FILED SIMULTANEOUSLY IN THE U.S. AND AUSTRALIA.
  • JAN 12, 2018: ORTHO DERMATOLOGICS ANNOUNCES U.S. FDA FILING ACCEPTANCE FOR IDP-121 ACNE TREATMENT IN LOTION FORM

Cassiopea is seeking marketing approval for clascoterone cream ##% for the treatment of acne.

  • Acne Treatment
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • Acne Treatment Continuum
  • Limitations of Commonly Used Acne Treatments

Rising medical tourism is one of the major trends in skin care treatment.

  • Acne Treatment
  • Dermatological Condition
  • Forecast
  • Allergan plc
  • Foamix Ltd.
  • ACNE TREATMENT ALGORITHM
  • MAJOR DRUG TARGETS FOR ACNE TREATMENT

SKIN THERAPY LETTER; ##(##): ##-##.

  • Acne Treatment
  • Foamix Ltd.
  • Galderma S.A.
  • Novan, Inc.
  • Valeant Pharmaceuticals International, Inc.
  • JAN 12, 2018: ORTHO DERMATOLOGICS ANNOUNCES U.S. FDA FILING ACCEPTANCE FOR IDP-121 ACNE TREATMENT IN LOTION FORM

Its twin drug candidate is a non-antibiotic topical cream developed for the treatment of acne vulgaris or acne.

  • Acne Treatment
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Aug 07, 2019: Ortho Dermatologics announces U.S. FDA filing acceptance for IDP-123 treatment for Acne Vulgaris in lotion form
  • Oct 15, 2019: Bausch Health's Ortho Dermatologics business to present data on acne drug tretinoin at The Fall Clinical Dermatology Conference

IS UNDER DEVELOPMENT FOR THE TREATMENT OF ACNE VULGARIS.

  • Acne Treatment
  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • FEATURED NEWS & PRESS RELEASES

Its twin drug candidate is a non-antibiotic topical cream developed for the treatment of acne vulgaris or acne.

  • Acne Treatment
  • Therapy
  • United States
  • Product Initiative
  • Syros Pharmaceuticals, Inc.
  • Clinical Trial profile. 160 Trial Title
  • Clinical Trial profile. 639 Trial Title

To Duac Topical Gel Clindamycin ##%/ Benzoyl Peroxide ##% (Stiefel) in the Treatment of Acne Vulgaris A Study Comparing Clindamycin ##%/ Benzoyl Peroxide ##% Topical Gel to Duac Topical Gel in the Treatment of Acne Vulgaris GDCT## NCT##

  • Acne Treatment
  • Clinical Trial
  • Dermatological Condition
  • World
  • Galderma S.A.
  • Clinical Trial profile. 539 Trial Title
  • Target

Gel for Treatment of Acne: A Pilot Study Effectiveness and Safety of Syzygium on Acne (ESSA) GDCT## TCTR##, Dermatology Acne Vulgaris Ongoing, recruiting Phase I/ II Interventional Syzygium Institute of Dermatology; Ministry of Public Health Thail

  • Acne Treatment
  • Anti-Infective
  • Clinical Trial
  • World
  • Galderma S.A.
  • Recommendations for Antibiotic Therapy in Acne Treatment
  • II. POOR TREATMENT COMPLIANCE

It is one of the top ## brands in the overall acne therapy market.

  • Acne Treatment
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • Recommendations for Antibiotic Therapy in Acne Treatment
  • II. POOR TREATMENT COMPLIANCE

It is one of the top ## brands in the overall acne therapy market.

  • Acne Treatment
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • AUG 07, 2019: ORTHO DERMATOLOGICS ANNOUNCES U.S. FDA FILING ACCEPTANCE FOR IDP-123 TREATMENT FOR ACNE VULGARIS IN LOTION FORM
  • OCT 15, 2019: BAUSCH HEALTH'S ORTHO DERMATOLOGICS BUSINESS TO PRESENT DATA ON TAZAROTENE AT THE FALL CLINICAL DERMATOLOGY CONFERENCE

FDA approval for the treatment of acne in more than ## years.

  • Acne Treatment
  • Therapy
  • United States
  • World
  • Clementia Pharmaceuticals Inc.
  • AUG 07, 2019: ORTHO DERMATOLOGICS ANNOUNCES U.S. FDA FILING ACCEPTANCE FOR IDP-123 TREATMENT FOR ACNE VULGARIS IN LOTION FORM
  • OCT 15, 2019: BAUSCH HEALTH'S ORTHO DERMATOLOGICS BUSINESS TO PRESENT DATA ON TAZAROTENE AT THE FALL CLINICAL DERMATOLOGY CONFERENCE

Its twin drug candidate is a non-antibiotic topical cream developed for the treatment of acne vulgaris or acne.

  • Acne Treatment
  • Therapy
  • World
  • Product Initiative
  • Syros Pharmaceuticals, Inc.

Its twin drug candidate is a non-antibiotic topical cream developed for the treatment of acne vulgaris or acne.

  • Acne Treatment
  • United States
  • World
  • Product Initiative
  • Syros Pharmaceuticals, Inc.
  • GALDERMA SA
  • AUG 07, 2019: ORTHO DERMATOLOGICS ANNOUNCES U.S. FDA FILING ACCEPTANCE FOR IDP-123 TREATMENT FOR ACNE VULGARIS IN LOTION FORM

Cassiopea is seeking marketing approval for clascoterone cream ##% for the treatment of acne.

  • Acne Treatment
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

Presence of alternatives for acne treatment ##. ##. ##.

  • Acne Treatment
  • OTC
  • APAC
  • Forecast
  • Target
  • Clinical Trial profile. 761 Trial Title

(Inactive) ## Sep 2009 ## Jan 2010 ## ## ## ## Efficacy Comparison Study of Topical Aminolaevulinic Acid-Photodynamic Therapy Versus Adapalene Gel ##. ##% Plus Doxycycline for Treatment of Moderate Acne Vulgaris.

  • Acne Treatment
  • Clinical Trial
  • Pharmaceutical
  • Therapy
  • World
  • Clinical Trial profile. 760 Trial Title
  • Clinical Trial profile. 680 Trial Title

CLINICAL TRIALS BY PHASE IN G## COUNTRIES ACNE AND RELATED DISORDERS THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* ACNE AND RELATED DISORDERS THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* ACNE AND RELATED DISORDERS THERAPEUTICS, G## COUNTRIES, CLI

  • Acne Treatment
  • Clinical Trial
  • Dermatological Condition
  • Pharmaceutical
  • World
  • Tretinoin Drugs for Acne Treatments
  • Nadifloxacin Drugs for Acne Treatments

It is one of the top ## brands in the overall acne therapy market.

  • Acne Treatment
  • Allergan plc
  • Cipla Ltd
  • Novartis AG
  • Sun Pharmaceutical Industries Limited
  • SEP 04, 2018: SOL-GEL TECHNOLOGIES PROVIDES PROGRAM UPDATE FOR TWIN FOR THE TREATMENT OF ACNE VULGARIS
  • DEC 17, 2018: SOL-GEL TECHNOLOGIES INITIATES PIVOTAL PHASE III CLINICAL PROGRAM OF TWIN FOR THE TREATMENT OF ACNE VULGARIS

Food and Drug Administration (FDA) for TWIN in the treatment of acne vulgaris.

  • Acne Treatment
  • United States
  • World
  • Product Initiative
  • Clementia Pharmaceuticals Inc.

Consumers buy these products with a curative goal in mind, not necessarily a preventive one, so there is not much incentive for manufacturers to create, for example, an anti-fungal treatment that also prevents the recurrence of fungal infections.

  • Acne Treatment
  • Skin Care
  • World
  • Demand
  • Market Competition
  • 1.4 TREATMENT
  • 3.2 THE US ACNE DRUGS REVENUE

Acne is one of today' s most significant skin concerns.

  • Acne Treatment
  • North America
  • United States
  • World
  • Allergan plc
  • Jan 12, 2018: Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121 Acne Treatment In Lotion Form

Its twin drug candidate is a non-antibiotic topical cream developed for the treatment of acne vulgaris or acne.

  • Acne Treatment
  • Therapy
  • United States
  • Product Initiative
  • Syros Pharmaceuticals, Inc.

Presence of alternatives for acne treatment ##. ##. ##.

  • Acne Treatment
  • APAC
  • World
  • Forecast
  • Market Size
  • 4.4 CURRENT PRESCRIPTION (RX) TREATMENTS FOR ACNE VULGARIS
  • 4.2 INCIDENCE AND PREVALENCE OF ACNE VULGARIS

TOPICAL CORTICOSTEROIDS ARE ONE OF THE EXTENSIVELY USED TREATMENTS.

  • Acne Treatment
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.

##.

  • Acne Treatment
  • OTC
  • APAC
  • World
  • Forecast